Thursday, March 30, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Defense + Military

DoD Awards Up to 900M in Medical Countermeasure Contracts

by Global Biodefense Staff
August 18, 2015
Biocoatings Development for Medical Devices

Credit: Shutterstock

The U.S. Department of Defense has recently awarded contracts to several companies in support of Medical Countermeasures Product Research and Development.

The period of performance for the effort is a base period of 5 years with a budget of $500,001,000. Five 1-year option periods, if exercised, could bring the total contract value is $900,000,000.

Task orders can be of the following types and will be determined per requirement at the task order level: Firm Fixed Price, Fixed Price Incentive Fee, Cost Plus Fixed Fee, Cost Plus Incentive Fee, Cost Plus Award Fee, or Time and Materials.

The selected awardees are:

  • Dynport Vaccine Company
  • PPD Development
  • TASC Inc.
  • Leidos Inc.

The overall objective is to facilitate the timely and efficient execution of the U.S. Army’s medical materiel development program by providing a mechanism for advanced medical product development and life cycle support, including pharmaceutical manufacturing and clinical research.

Source: DoD.gov

Tags: AwardsVaccines

Related Posts

Medical Countermeasures

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
Load More

Latest News

Scientists Design Molecule to Slow SARS-Cov-2 Infection

March 29, 2023

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC